MedMira (MedMira) Change In Inventory : $-0.02 Mil (TTM As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is MedMira Change In Inventory?

MedMira's change in inventory for the quarter that ended in Jan. 2024 was $-0.03 Mil. It means MedMira's inventory increased by $0.03 Mil from Oct. 2023 to Jan. 2024 .

MedMira's change in inventory for the fiscal year that ended in Jul. 2023 was $0.02 Mil. It means MedMira's inventory declined by $0.02 Mil from Jul. 2022 to Jul. 2023 .

MedMira's Total Inventories for the quarter that ended in Jan. 2024 was $0.16 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. MedMira's Days Inventory for the quarter that ended in Jan. 2024 was 217.48.

Inventory Turnover measures how fast the company turns over its inventory within a year. MedMira's Inventory Turnover for the quarter that ended in Jan. 2024 was 0.42.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. MedMira's Inventory-to-Revenue for the quarter that ended in Jan. 2024 was 1.29.

MedMira Change In Inventory Historical Data

The historical data trend for MedMira's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Change In Inventory Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Change In Inventory

Get a 7-Day Free Trial

0.06

-0.09

-0.01

0.03

0.02

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Inventory	Get a 7-Day Free Trial															0.01	-	-	-	-0.03

MedMira Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02 Mil.

MedMira (OTCPK:MMIRF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

MedMira's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.143	/	0.06	*	365 / 4
	=	217.48

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

MedMira's Inventory Turnover for the quarter that ended in Jan. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.06	/	0.143
	=	0.42

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

MedMira's Inventory to Revenue for the quarter that ended in Jan. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.143	/	0.111
	=	1.29

MedMira Change In Inventory Related Terms

Thank you for viewing the detailed overview of MedMira's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.